France· FR:66055652
MAGNESIUM CHLORURE RENAUDIN 10 % (0,1 g/ml), solution injectable (IV) en ampoule
A medicinal product containing chlorure de magnésium hexahydraté, registered in France by LABORATOIRE RENAUDIN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORURE DE MAGNÉSIUM HEXAHYDRATÉ
- Manufacturer
- LABORATOIRE RENAUDIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093664315410 ampoule(s) bouteille en verre de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorure de magnésium hexahydraté in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBestmade Natural Products Mag CarbBestmade Natural Products
- United Kingdom100 M-Trate capsulesTriOn Pharma Ltd
- SwitzerlandAndreamag
- BelgiumCarbobel SimplexMedgenix Benelux
- Japanクエン酸マグネシウム堀井薬品工業
- NorwayEmgesanMeda AS
- GermanyBiolectra ForteHermes Arzneimittel Gmbh
- CzechiaMAGNESII LACTICI 0,5 TBL. MEDICAMENTAGlenmark Pharmaceuticals s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Biolectra, Dr. Böhm Direkt
- Belgium · Magmedi, Magneclo
- Bulgaria · Диаспорал Директ, Магнезиев Диаспорал
- Cyprus · Magnesia San Pellegrino
- Czechia · Magnesii Lactici Medicamenta, Magnesium Lactate Biomedica
- Germany · Biolectra Forte, Biolectra Forte Orangengeschmack
- Denmark · Diasporal, Magnesia
- Estonia · Magnesium Diasporal Protina Pharmazeutische Gesellschaft Mbh, Magnesium Diasporal Protina Pharmazeutische Gmbh
- Spain · Magnesia Cinfa, Magnesia Lainco
- Finland · Emgesan, Magnesiamaito
- United Kingdom (Northern Ireland) · Magnaspartate, Magnesium Hydroxide Mixture Brown & Burk Uk
- Greece · Chymexan, Davimag
- Hungary · Antagel M, Magnesii Citrici Naturland
- Ireland · Magmedi, Magnence
- Iceland · Magnesia Dak
- Italy · Citrato Espresso Gabbiani, Magnesia
- Lithuania · Diasporal, Diasporal Direct
- Luxembourg · Emge, Mag 2
- Latvia · Diasporal, Magnesium Diasporal Direct Protina Pharmazeutische
- Malta · Magnesia
- Netherlands · Magmedi, Magnence
- Norway · Nycoplus
- Poland · Magnezin, Slow-Mag
- Portugal · Leite De Magnésia Phillips, Magnoral
- Sweden · Magnesium Eql Pharma, Magnesium Evolan
- Slovenia · Magnesium Protina, Magnesol
- Slovakia · Magnesii Lactas Galvex, Magnesii Lactas Vulm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbff7529-a603-4514-aba2-8e70973356fc GET /v1/drugs/bbff7529-a603-4514-aba2-8e70973356fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66055652",
"date_amm": "2000-04-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORURE DE MAGNÉSIUM HEXAHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorure de magnésium hexahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.